Home Echo Therapeutics

Echo Therapeutics

In operation
IPO
Non-invasive Continuous Blood Glucose Monitor Developer

Basic Information

Echo Therapeutics Inc. developed Symphony, a non-invasive continuous glucose monitoring system that uses skin dialysis to collect glucose concentrations from subcutaneous tissue fluid. Symphony® CGM is a non-invasive, wireless system capable of continuously monitoring glucose levels for 24 hours, designed for use in hospital intensive care units and by diabetes patients.
Echo Therapeutics Inc.
NewYork,United States of America
15~50 people
January 01, 1989
info@echotx.com